April 2008 The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: www.ispor.org. Please share these new ISPOR activities with your colleagues. MEETINGS ISPOR 13th Annual International Meeting, Toronto, Canada- OVER 1,100 ABSTRACTS SUBMITTED! (60% INCREASE) The 13th Annual International Meeting, "Vive la Différence - Enhancing/Expanding Outcomes Research One Country at a Time," will be held May 3-7, 2008, at the Sheraton Centre Toronto, Toronto, ON, Canada. For more information see: ISPOR 13th International Meeting >> ISPOR 3rd Asia-Pacific Conference, Seoul, South Korea ~300 ABSTRACTS SUBMITTED (26% INCREASE) The 3rd Asia-Pacific Conference "Evidence-based Health Care Decision Making in Asia Pacific: The Application of Pharmacoeconomics and Outcomes Research" will be held 7-9 September 2008. Abstract submission ends on 17 March 2008. Exhibit, symposium and sponsorship opportunities are now available. For more information see: ISPOR 3rd Asia-Pacific Conference >> ISPOR 11^th Annual European Congress, Athens, Greece The 11th Annual European Congress, "Moving and Improving Concepts & Evidence for Health Care Decisions" will be held 8-11 November 2008. Exhibit and sponsorship opportunities are now available. For more information see: 11th Annual European Congress >> ISPOR CONSORTIUM NEWS NEW! ISPOR Asia Consortium developed the survey, "Pharmacoeconomics and Outcomes Research Needs Assessments," to assess needs in the Asia-Pacific region. You are encouraged to complete the survey that is available to be downloaded from ISPOR website at: ISPOR Asia Consortium >> The survey is available in Spanish through the ISPOR Latin America Consortium website. ISPOR Latin America Consortium >> Return surveys to: peorsurvey@ispor.org by 15 April 2008. ISPOR LOCAL CHAPTER NEWS NEW! ISPOR is proud to announce the establishment of its newest chapter, ISPOR Venezuela Local Chapter. The president of the Chapter is Yajiara Bastardo PhD., Professor, School of Pharmacy, Central University of Venezuela. For more details and information, go to: ISPOR Venezuela Local Chapter >> The ISPOR Brazil Local Chapter will host its 2nd Annual Conference, "Education & Application of Pharmacoeconomics in Brazil", 7-9 April 2008, in São Paulo, Brazil. This follows on its inaugural conference held March 2007 with over 250 attendees! For more details and information, visit: ISPOR Brazil Local Chapter >> NEW! The ISPOR Thailand Chapter’s Annual Conference 2008 “Pharmacoeconomics and Outcomes Research in Thailand: A Stepping Stone toward National Drug Policy” will be held from May 12-13, 2008, in Bangkok, Thailand. For the Conference Program, go to: ISPOR Thailand Local Chapter >> NEW! The ISPOR Hungary Local Chapter and The Hungarian Health Economics Association (META) will host the second National Congress of Health Economics on July 9, 2008 For more information, go to: ISPOR Hungary Local Chapter >> NEW! The ISPOR Russia Local Chapter will be presenting a forum at the ISPOR 13th Annual International Meeting. For program information, go to: ISPOR Russia Local Chapter >> VALUE IN HEALTH NEW! Value in Health Volume 11, Issue 2 On-Line Value in Health Volume 11, Issue 2 is now available on-line. Featured in this issue in economic evaluation: "HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan," by David L. Veenstra et al.; in outcomes assessment: “Comparing the Standard EQ-5D Three-Level System with a Five-Level Version,” by Mathieu F. Janssen et al.; and policy analysis: “Adoption of Pharmaceutical Innovation and the Growth of Drug Expenditure in Taiwan: Is It Cost Effective?” by Chee-Ruey Hsieh and Frank A. Sloan. Value in Health >> ISPOR CONNECTIONS NEW! The ISPOR CONNECTIONS Editorial Board is seeking articles on economic evaluation, outcomes assessment, and policy analysis from the ISPOR 13th Annual International Meeting. If you had a podium or poster presentation accepted for this meeting and would like to submit an article based on this presentation for consideration, go to: ISPOR CONNECTIONS Article Guidelines and Submission >> SPECIAL INTEREST GROUPS/TASK FORCES The following are ISPOR Special Interest Groups (SIG) and Task Force forums held at the ISPOR 13th Annual International Meeting May 2-7, 2008, in Toronto, ON, Canada. Monday, May 5, 2008–7:30-8:30AM Multinational Trials - What Translations Are Required, What Methodology Should Be Used And What Methodology Supports Pooling The Data? Changing Culture or Language of an Instrument presented by the ISPOR Patient Reported Outcomes (PRO) Task Force Registry Design, Operations, Data & Taxonomy presented by the ISPOR Patient Registry SIG ISPOR Digest of International Databases presented by the ISPOR Retrospective Databases SIG For descriptions and speakers for Monday ISPOR Forums, go to: Monday ISPOR Forums >> Tuesday, May 6, 2008 Navigating The Health Technology Assessment Process Around The World presented by ISPOR Health Technology Assessment SIG Pharmacoeconomic and Outcomes Research Fellowship Standards presented by the ISPOR Fellowship Standards Task Force Assessment Determinants and Economics of Medication Compliance and Persistence presented by the ISPOR Medication Compliance & Persistence SIG Design and Analysis of Non-Randomized Studies of Treatment Effects using Secondary Databases presented by the ISPOR Good Research Practices for ISPOR Retrospective Database Analysis Task Force Good Research Practices On Economic Data Transferability presented by the ISPOR Good Research Practices On Economic Data Transferability Task Force Quality Improvement in Cost-Effectiveness Research presented by the ISPOR Quality Improvement in Cost-Effectiveness Research (QICER) Task Force Overview of Decision Analysis and its Application presented by the ISPOR Student Network For descriptions and speakers for Tuesday ISPOR Forums, go to: Tuesday ISPOR Forums >> ISPOR AWARDS NEW! ISPOR Scientific Achievements Awards The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievements in pharmacoeconomics and out comes research. The 13th Annual International Meeting will recognize the following awardees at the ISPOR Awards Ceremony immediately following the 2nd Plenary Session on Tuesday, May 6, 2008: 2008 ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Awardee Bryan R. Luce PhD, MBA 2008 ISPOR Research Excellence for Methodology Awardee Andrea Manca PhD, MSc, for the paper, “Cost-Effectiveness Analysis Using Data from Multinational Trials: The Use of Bivariate Hierarchical Modeling,” Medical Decision Making 2007;27:471-90. 2008 ISPOR Research Excellence for Practical Application Awardee Gregory S. Zaric PhD, for the paper, “A Little Planning Goes a Long Way: Multilevel Allocation of HIV Prevention Resources,” Medical Decision Making 2007;27:71–81 2008 ISPOR Bernie O’Brien New Investigator Awardee Patrick W. Sullivan PhD 2008 International Fellowship Awardees Federico Augustovski MD, MSc Mohammed Fouad Jabr, RPh, PharmD, MBA, MSc, BSc Yot Teerawattananon MD, PhD ISPOR Scientific Achievement Awards >> TIP OF THE MONTH- ISPOR Research To view ISPOR’s Health Science Initiatives, Patient Reported Outcomes, and QOL Activities & Accomplishments from 1999 – 2006, go to the “Research” Tab on the purple tool bar and select “ISPOR Research Initiatives. << **************Advertisements************** >> August 18-20, 2008 Harvard School of Public Health, Boston, MA                   Improve your analytical and quantitative skills                        to enhance health outcomes research This program is geared to introductory-intermediate learning levels to help participants design, implement, and analyze outcomes studies, and critically review and use outcomes data for clinical decision making, health care planning, and technology development. The course provides participants with an overview of several topics in the exciting new field of health outcomes, equipping new comers with knowledge of the language and concepts. In an increasingly competitive health care market, outcomes evaluation, and research is important for: * Improving patient outcomes     * Controlling costs and allocating resources     * Implementing disease management programs     * Making effective clinical and business decisions     * Developing and marketing health care products and services "The program fully met my high expectations and had great practical relevance, which was important to me as a clinician." - Kevin James Mulhall, MD, Orthopedic Surgery, University of Virginia Fontaine Research Park CME and CEU Credits Available. For a detailed agenda  or to register, visit: Harvard School of Public Health, Center for Continuing Professional Education or call (617) 384-8692. Please be sure to mention your Reference Code: MDA08-IP2 in all correspondence. Q: What will my contributions mean for patients? A: Answers. For more than 130 years, Lilly has been dedicated to meeting the health care needs of people in the United States and around the world.  We address these needs primarily by developing innovative medicines—investing a higher percentage of our sales in research and development than any other major pharmaceutical company. Eli Lilly and Company is expanding its Global Health Outcomes function and is seeking qualified candidates for the following positions: The Outcomes Research Scientist is responsible for the conduct, quality, and integrity of health outcomes studies and scientific disclosures resulting from their research.  The Scientist effectively communicates health outcomes findings and concepts to internal and external business partners and takes a leadership role in the dissemination of health outcomes research findings to the scientific community.  Projects may focus on treatments that Lilly is developing and span the entire lifecycle of development and commercialization.  Other projects may focus on key health care policy issues that impact patient outcomes.  Qualified candidates will hold an advanced degree, including Ph.D., M.D., or master’s degree in a relevant discipline (e.g., economics, epidemiology, health administration, pharmacy, health services, medicine, pharmacoeconomics, psychology, statistics, or other relevant sciences) with at least 2 years of experience.  Significant experience in designing, conducting research, and disseminating the results in the areas of health economics, economic modeling, clinical trials, cost-effectiveness evaluation, PRO instrument development, observational/epidemiologic research, health technology assessment, and/or health care policy may substitute for the formal degree requirement.  Clinical or therapeutic expertise in the areas of neuroscience, oncology, diabetes, obesity, cardiovascular, acute care, musculoskeletal, or inflammation is desired. The Outcomes Liaison (OL) serves as the scientific interface between Lilly’s Outcomes Research function and value based population decision makers by answering unsolicited questions, providing disease state, therapy specific, and pharmacoeconomic information to external customers in Managed Care, Medicaid, and Institutional settings. Qualified candidates will have a PharmD, MSN, MPH, MHA, Ph.D., or have an undergraduate clinical degree (i.e. nursing, pharmacy) with an MBA, MS in a relevant discipline.  Candidates must have experience in designing, conducting, communicating, or applying outcomes research; relevant clinical experience in the managed care environment; understanding of FDA regulations related to the submission of pharmacoeconomic data and requirements for pharmacoeconomic promotion and labeling; and population-based health care management experience. All qualified candidates must be legally authorized to be employed in the United States.  Eli Lilly and Company does not anticipate providing sponsorship for employment visa status (e.g., H-1B status) for these current opportunities. For more information or to apply, visit: www.lilly.com/careers.  Eli Lilly and Company is an equal opportunity employer. << **************Advertisements************** >> This newsletter is provided as a benefit of membership in ISPOR. If you received this from a colleague and are not a current ISPOR member, please consider becoming an individual member or organizational affiliate.  Contact membership services for more information and its use in health care decisions. The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research. 3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA Tel: 609-219-0773 Toll Free: 1-800-992-0643 Fax: 609-219-0774

IMPORTANT DATES TO REMEMBER 7-9 April 2008 ISPOR Brazilian Local Chapter 2^nd Annual Conference More >> 16-20 April 2008 ISPOR Turkey Local Chapter Summer School More >> 12-13 May 2008 ISPOR Thailand Chapter Annual Conference More >> 23 June 2008 Abstract submission Deadline ISPOR 11th Annual European Congress More >> QUICK LINKS 13th Annual International Meeting 3^rd Asia-Pacific Conference 11th Annual European Congress Value in Health ISPOR CONNECTIONS ISPOR Book of Terms Special Interest Groups (SIGs) Student Network ISPOR Speakers' Bureau Local Chapters ISPOR Latin America Consortium ISPOR Asia Consortium ISPOR Asia-Pacific Medial Device & Diagnostics Council Membership Employment